Search Results for "ranolazine"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for ranolazine. Results 1 to 3 of 3 total matches.
See also: Ranexa

Mavacamten (Camzyos) for Obstructive Hypertrophic Cardiomyopathy

   
The Medical Letter on Drugs and Therapeutics • Jun 13, 2022  (Issue 1652)
with disopyramide or ranolazine. It can be used with a beta blocker or a nondihydropyridine calcium channel ...
The FDA has approved mavacamten (Camzyos – MyoKardia/BMS), a modulator of cardiac myosin, to improve functional capacity and symptoms in adults with New York Heart Association (NYHA) class II or III obstructive hypertrophic cardiomyopathy (HCM) who have a baseline left ventricular ejection fraction (LVEF) ≥55%. Mavacamten is the first drug in its class to become available in the US.
Med Lett Drugs Ther. 2022 Jun 13;64(1652):89-91 |  Show IntroductionHide Introduction

Comparison Table: Some Lipid-Lowering Drugs (online only)

   
The Medical Letter on Drugs and Therapeutics • Sep 19, 2022  (Issue 1659)
, or verapamil and 20 mg if taken with amiodarone, amlodipine, or ranolazine. 7. Inhibitors and inducers of CYP ...
View the Comparison Table: Some Lipid-Lowering Drugs
Med Lett Drugs Ther. 2022 Sep 19;64(1659):e152-6 |  Show IntroductionHide Introduction

Lipid-Lowering Drugs

   
The Medical Letter on Drugs and Therapeutics • Sep 19, 2022  (Issue 1659)
with amiodarone, amlodipine, or ranolazine. 14. Not recommended for use in patients with moderate to severe ...
Cholesterol management guidelines from the American College of Cardiology/American Heart Association Task Force were last published in 2019.
Med Lett Drugs Ther. 2022 Sep 19;64(1659):145-52 |  Show IntroductionHide Introduction